Freedman Financial Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Freedman Financial Associates's MRK Position: Q2 2022 in Review
Freedman Financial Associates sold out of Merck (MRK) in Q2 2022, closing a stake of 4,618 shares — an estimated $386K sold.
Freedman Financial Associates first reported a position in MRK in Q4 2020 and held it in 6 quarters. The position peaked at $386K in Q1 2022. 3,013 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Freedman Financial Associates reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
- Freedman Financial Associates sold 4,618 Merck shares in Q2 2022, an estimated $386K.
- Freedman Financial Associates first reported a position in Merck in Q4 2020 and held it in 6 quarters.
- Freedman Financial Associates's Merck position peaked at $386K in Q1 2022.
- 3,013 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Freedman Financial Associates's 13F filing for Q2 2022.